Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Phase II Study of PHA-739358 in t(4;14) Multiple Myeloma
2007-005425-30Phase 2Completed
- Sponsor
- Nerviano Medical Sciences
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of danusertib in multiple myeloma (MM), sponsored by Nerviano Medical Sciences. Primary endpoint: Primary response rate. Started Feb 2008; status: completed.
02
Drugs
danusertib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2007-005425-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005425-30.